Menu ×


Entropion Treatment Market Segmentation by Type (Congenital, Paralytic, and Others); by Treatment (Artificial Tears, Skin Tape, Anti-inflammatory Drugs, Surgery, and Others); and by End-User (Specialty Clinics, Hospital, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Entropion Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


  • July, 2021: Bausch & Lomb Incorporated, announced the launch of hydration boost lubricant eye drops and micellar eyelid cleansing wipes, under the brand name BioTrue.

  • October, 2020: Novartis AG to acquire Vedere Bio, in order to expand its portfolio to ophthalmology and opto-genetic gene therapy technology for treating blindness.

Global Entropion Treatment Market Highlights over 2022 – 2030

The global entropion treatment market is estimated to grow at a significant CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the growing cases of entropion amongst the geriatric population globally. Entropion is a condition in which the eyelid folds inwards, and can happen in either eyelid. It can lead to corneal ulcer, retinal infection, and even vision impairment due to corneal damage. According to the data by the World Health Organization (WHO), corneal opacities cause moderate to severe distance vision impairment or loss of vision in over 4.2 million people. Meanwhile, 2.2 billion people suffer from partial or complete blindness globally. The growing awareness regarding optical diseases, and penetration of healthcare services in remote areas worldwide are some of the major factors anticipated to drive the market growth.

Entropion Treatment Market GraphMoreover, the growing global geriatric population is also estimated to boost the market growth, as entropion is more common in old age. According to the World Bank census, the total share of global population aged above 65 years in 2020 was 9.318%, up from 8.223% in 2015, and this share is expected to further increase in the upcoming years. CLICK TO DOWNLOAD SAMPLE REPORT

Population Aged above Image

The market is segmented by treatment into artificial tears, skin tape, anti-inflammatory drugs, surgery, and others, out of which, the surgery segment is anticipated to hold the notable share in the global entropion treatment market over the forecast period as surgery is required in almost every critical case of entropion. Along with this, the artificial tears segment is also estimated to gain significant share during the forecast period owing to the high application of this treatment method in mild cases of entropion.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Entropion Treatment Market Regional Synopsis

On the basis of geographical analysis, the global entropion treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of large geriatric population in countries, such as India and China. According to the data by the World Bank, the population above 65 years of age in India crossed 90,719,952 in 2020, while, it crossed 167,808,567 in China. Moreover, improving healthcare facilities, and rising health awareness amongst the people, are projected to boost the market growth. The market in North America region is anticipated to gain the largest market share throughout the forecast period on account of the presence of major pharmaceutical companies in the United States, along with efficient medical facilities available in the region. Moreover, the favorable reimbursement and health insurance policies in the region, combined with high individual disposable income, are projected to boost the market growth.

Entropion Treatment Market Share Image

The global entropion treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global entropion treatment market includes the following segments:

By Type

  • Congenital
  • Paralytic 
  • Others

By Treatment

  • Artificial Tears
  • Skin Tape
  • Anti-inflammatory Drugs
  • Surgery
  • Others

By End-User

  • Specialty Clinics
  • Hospital
  • Others

Growth Drivers

  • Growing Geriatric Population Globally
  • Increasing Global Healthcare Expenditure  


  • Complications Related to Eye Surgeries
  • Lack of Awareness Regarding Ophthalmic Disorders

Top Featured Companies Dominating the Market

  • Alembic Limited
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Eli Lilly and Company
  • Bausch & Lomb Incorporated
  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • Sanofi-aventis Groupe
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Siemens Healthcare GmbH
  • Pfizer Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved